Searchable abstracts of presentations at key conferences in endocrinology

ea0014p566 | (1) | ECE2007

Cerebrospinal fluid (CSF)/serum albumin ratio shows no alteration of the blood-brain barrier in patients with pituitary adenomas and high CSF levels of pituitary hormones

Gheorghiu Monica Livia , Purice Mariana , Rusu Catrinel , Galoiu Simona , Tanasescu Ruxandra , Niculescu Dan , Coculescu Mihai

Some patients with pituitary adenomas show high CSF levels and/or high CSF/serum ratio for peptidic pituitary hormones (PR), potentially due to a blood-brain barrier (BBB) damage. We evaluated albumin.CSF/serum ratio (AR) in patients with pituitary adenomas and elevated PR, as an accurate index for a BBB damage.Patients and methods: We evaluated 10 controls (21–79 years, 6M /4 F) before undergoing abdominal or peripheral surgery and 52 patients with...

ea0056p734 | Endocrine tumours and neoplasia | ECE2018

Comparison of clinical and subclinical apoplexy in pituitary adenomas

Gheorghiu Monica Livia , Bouariu Alexandra , Trifanescu Raluca Alexandra , Poiana Catalina , Badiu Corin

Pituitary apoplexy is a rare syndrome due to a clinically overt hemorrhagic infarction, described in 2–7% of pituitary adenomas. A subclinical usually asymptomatic pituitary hemorrhage and/or infarction may be detected on routine imaging or during histopathological examination in 25–28% of patients with pituitary adenomas.Aim: We compared the clinical features and evolution of 166 patients with subclinical pituitary apoplexy (SPA) and 46 patien...

ea0056p1102 | Thyroid (non-cancer) | ECE2018

Conversion from thyroxine-treated autoimmune hypothyroidism to Graves’ disease

Gheorghiu Monica Livia , Burciulescu Sofia Maria Lider , Purice Mariana , Alexiu Florin

Graves’ disease (GD) and Hashimoto’s thyroiditis (HT) are both autoimmune thyroid diseases. While transition from GD to hypothyroidism has been more frequently reported, conversion of hypothyroidism to GD is uncommon. We describe a series of 3 patients diagnosed with HT and hypothyroidism, treated with L-thyroxine (LT4), who developed persistent hyperthyroidism with increased thyrotropin receptor antibodies (TRAb) levels and, in two of the patients, Graves’ opht...

ea0056p1159 | Thyroid cancer | ECE2018

Analysis of the prognostic factors during I-131 therapy for differentiated thyroid cancer patients using BIOMAT ENDO data base

Purice Mariana , Andreea Chiriac Iulia , Radulescu Monica , Livia Gheorghiu Monica , Goldstein Andrei-Liviu

BIOMAT-ENDO software is a Windows Forms application that stores all the main data regarding the patients with thyroid cancer (TC) hospitalized in the Nuclear Medicine Department of the National Institute of Endocrinology in Bucharest, starting with the first hospitalization, continuing with the periods of radioiodine therapy (RIT) and the follow up. Patient-monitoring MODULE contains clinical parameters, surgery details, in Vivo and in Vitro investig...

ea0073aep735 | Thyroid | ECE2021

Block-replace therapy in the management of Graves’ disease

Ana-Maria Stancu , Gheorghiu Monica , Purice Mariana , Alexandrescu Daniela , Badiu Corin

IntroductionAnti-thyroid drugs (ATDs) are the first line treatment in Europe for hyperthyroidism due to Graves’ disease (GD). Adding levothyroxine to ATDs, so called block and replace therapy (BRT) is still controversial.AimTo follow up the outcomes after treating patients with Graves’ disease in a block and replace regimen.Patients & methodsA prospe...

ea0073ep158 | Pituitary and Neuroendocrinology | ECE2021

Rapid decrease of a pituitary mass with gonadotrophic and thyrotrophic insufficiency – the case for lymphocytic hypophysitis?

Livia Gheorghiu Monica , Irina Andreea Bunea , Sofia Maria Lider Burciulescu , Anda Dumitrascu , Ramona Aldea

BackgroundLymphocytic hypophysitis is an unusual inflammation of the pituitary gland affecting mostly women. Its pathogenesis is still poorly understood and the presentation and clinical course vary largely. Serum prolactin levels may be low, normal, or elevated. Unlike what is observed in clinically nonfunctioning pituitary adenomas, there is not a clear hierarchy of anterior pituitary hormone deficiencies. Hypophysitismay resolve spontaneously, may rel...

ea0073ep197 | Thyroid | ECE2021

Transient thyrotoxicosis after laryngeal carcinoma surgery

Sofia Maria Lider Burciulescu , Costache Outas Mariana , Bunea Irina , Livia Gheorghiu Monica

IntroductionThyrotoxicosis debuted early after thyroid lobectomy is described in approximately 54% of cases. It has also been described in a few case reports after non thyroid neck surgeries or in invasive laryngeal cancer after total laryngectomy and debulking hemithyroidectomy.Case presentationPatient aged 53 years old, known with laryngeal carcinoma of 37/28/40 mm located at piriform sinus, linked by the l...

ea0074ncc27 | Highlighted Cases | SFENCC2021

Hyperandrogenism and breast cancer in a postmenopausal woman – treatment challenges

Lider Burciulescu Sofia Maria , Dumitrascu Anda , Vladoiu Suzana , Caragheorgheopol Anda , Gheorghiu Monica Livia

Introduction: New-onset hyperandrogenism is rare in postmenopausal women and is usually associated with causes such as ovarian hyperthecosis, androgen-secreting tumor or medication. Patients with hyperandrogenism and breast cancer need a special attention when choosing the treatment.Case history: A 46-year old woman diagnosed with hormone receptor-positive breast cancer at 37 years old, for which she underwent surgery, chemotherapy, radiotherapy and horm...

ea0093p6 | Guided Poster Tour 1: Adrenal and Neuroendocrine tumors | EYES2023

New possible pathogenic variants involved in pheochromocytomas and paragangliomas

Burciulescu Sofia Maria Lider , Gheorghiu Monica Livia , Patocs Attila , Braha Elena Emanuela , Badiu Corin

New possible pathogenic variants involved in pheochromocytomas and paragangliomasIntroduction: Pheochromocytomas and paragangliomas (PPGLs) are rare tumors of the chromaffin tissues that store and release catecholamines in excess. Most pheochromocytomas are sporadic, usually resulting in unilateral adrenal tumor, but 25–45% harbour a germline mutation.Aim: To describe new possible pathogenic variants (VUS) involved in PPGLs.</...

ea0099p332 | Pituitary and Neuroendocrinology | ECE2024

Sarcoma of the sphenoid sinus occurring 34 years after fractionated sellar 60Cobalt radiotherapy for acromegaly

Maria Prunariu Ana , Popescu Mihaela , Stoica Sergiu , Costache Outas Mariana , Dumitrascu Anda , Livia Gheorghiu Monica

Introduction: Treatment options for acromegaly include surgery or radiation to remove or reduce the size of the tumor and medication to help normalize the hormone levels. While improving the prognosis, patients with acromegaly treated with radiotherapy are at risk of long-term development of secondary malignancies (1-2% at 10-20 years). We report the case of a 55-year old woman diagnosed with high-grade sarcoma of the sphenoid sinus developed 34 years after receiving 60Cobalt ...